Many US multiple sclerosis patients aren't receiving the latest drug therapies News-Medical-Net Thu, 05 Apr 2007 10:04 PM PDT Immunomodulatory agents (IMAs) could slow the progress of the disease, but are only prescribed in a minority of cases, and mostly by neurologists.

MS Patients Need Better Socio-economic Support As Well As Medical Care Medical News Today Thu, 05 Apr 2007 7:04 PM PDT People with multiple sclerosis need much more practical help and better care support, according to a study published in the latest Journal of Advanced Nursing.Researchers from King's College London explored the aspirations of 445 patients with different levels of multiple sclerosis (MS), who were taking part in a wider study to evaluate MS specialist nurses. [click link for full article]

Few Private Insurance Plans Provide Brand-Name Prescription Drug Coverage During Medicare 'Doughnut Hole' Medical News Today Fri, 06 Apr 2007 8:04 AM PDT The Los Angeles Times on Monday examined the lack of private health insurers offering brand-name prescription drug coverage for Medicare beneficiaries during the so-called "doughnut hole" coverage gap. Under the doughnut hole, beneficiaries are responsible for 100% of total prescription drug costs between $2,400 and $5,450. Medicare then covers 95% of prescription drug costs beyond $5,450. [click ...

Choosing the Best Form of Vitamin D
RedNova Fri, 06 Apr 2007 6:01 AM PDT
Q: My doctor recommended I take supplemental vitamin D. Because of ongoing fatigue problems due to MS and fibromyalgia, she tested my vitamin D level. It was just above 20, which she said was too low.